| 1 |
33789933 | GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients. | 2021 Nov |
1 |
| 2 |
34452121 | 68Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [68Ga]Ga-RM2. | 2021 Jul 28 |
1 |
| 3 |
31895261 | The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin αvβ3 receptor levels in patients with breast cancer. | 2020 Mar |
1 |
| 4 |
32433170 | The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization Algorithm. | 2020 Jul |
1 |
| 5 |
31246685 | 68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate Cancer. | 2019 Sep |
1 |
| 6 |
30036253 | 68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study. | 2018 Sep |
1 |
| 7 |
26449838 | 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients. | 2016 Jan |
2 |
| 8 |
24633452 | A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. | 2014 Jun |
2 |
| 9 |
19360404 | (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. | 2009 Sep |
1 |
| 10 |
20641746 | 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14] | 2004 |
1 |
| 11 |
23057095 | 68Ga-1,4,7-Triazacyclononane-1,4-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | 2004 |
2 |